Showing results (141-150 of 697) with videos related to

Sort By:
Pageof 70
Diabetes|April 2, 1999
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissueP E Morange, J Aubert, F Peiretti, et al.
British Journal of Haematology|December 21, 2004
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohortP E Morange, D A Tregouet, C Frere, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1993
Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodiesM Berard, M C Boffa, M Karmochkine, et al.
Thrombosis Research|May 23, 2001
Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime studyP Y Scarabin, M F Aillaud, G Luc, et al.
Circulation|March 17, 2004
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) studyP E Morange, C Simon, M C Alessi, et al.
Texas Heart Institute Journal|December 1, 1984
Coronary thrombolysis with tissue-type plasminogen activator: prospective reviewD Collen D
Thrombosis and Haemostasis|October 28, 1987
Measurement of low molecular weight heparin ex vivo activities in clinical laboratories using various anti-Xa assays: interlaboratory variability and requirement for an agreed low molecular weight heparin standardP Sié, M F Aillaud, D de Prost, et al.
European Cytokine Network|August 1, 1991
Interleukin-2 induces chemotactic deficiency in patients with onco hematologic malignancies and autologous bone marrow transplantationA M Stoppa, C Fossat, D Blaise, et al.
La Revue De Medecine Interne|January 1, 1987
[Detection of platelet antibodies in idiopathic thrombopenic purpura]J M Durand, D Sasportas, M A Prince-Zucchelli, et al.
European Journal of Human Genetics : EJHG|September 16, 2004
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME StudyP E Morange, L Tiret, N Saut, et al.
Pageof 70